- Report
- May 2022
- 36 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 37 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 35 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 41 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 72 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 101 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 82 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 53 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- November 2021
- 844 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Report
- November 2021
- 365 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Book
- March 2022
- 896 Pages
- Book
- January 2020
- 424 Pages
- Book
- November 2013
- 744 Pages
- Book
- October 2018
- 702 Pages

Interferon is a type of biotechnology used to treat a variety of diseases, including cancer, hepatitis, and multiple sclerosis. It is a naturally occurring protein produced by the body in response to viral infections. Interferon works by stimulating the immune system to fight off the virus, and can also be used to reduce inflammation and slow the growth of tumors.
Interferon is available in both natural and synthetic forms, and is used in a variety of treatments. It is often used in combination with other drugs, such as chemotherapy, to increase the effectiveness of the treatment. Interferon is also used in gene therapy, where it is used to introduce new genes into cells to treat genetic diseases.
The interferon market is highly competitive, with many companies offering different types of interferon products. Some of the major players in the market include Roche, Merck, Novartis, and GlaxoSmithKline. These companies are constantly developing new products and technologies to improve the effectiveness of interferon treatments. Show Less Read more